Equities analysts forecast that Safeguard Scientifics, Inc (NYSE:SFE) will announce $1.53 earnings per share (EPS) for the current fiscal quarter, according to Zacks. Zero analysts have provided estimates for Safeguard Scientifics’ earnings. Safeguard Scientifics posted earnings per share of ($1.21) in the same quarter last year, which indicates a positive year-over-year growth rate of 226.4%. The company is expected to announce its next earnings report on Thursday, July 25th.

On average, analysts expect that Safeguard Scientifics will report full year earnings of $1.37 per share for the current year. For the next fiscal year, analysts expect that the firm will report earnings of ($1.70) per share. Zacks’ EPS calculations are a mean average based on a survey of research firms that that provide coverage for Safeguard Scientifics.

Safeguard Scientifics (NYSE:SFE) last released its quarterly earnings data on Thursday, May 2nd. The asset manager reported $1.05 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.80 by $0.25.

Several equities research analysts have recently issued reports on the stock. ValuEngine upgraded shares of Zogenix from a “buy” rating to a “strong-buy” rating in a research report on Thursday, June 27th. Zacks Investment Research cut shares of GENEL ENERGY PL/ADR from a “buy” rating to a “hold” rating in a research report on Tuesday, May 7th.

Several institutional investors have recently added to or reduced their stakes in SFE. Yakira Capital Management Inc. grew its holdings in shares of Safeguard Scientifics by 2.7% in the first quarter. Yakira Capital Management Inc. now owns 818,289 shares of the asset manager’s stock valued at $8,878,000 after purchasing an additional 21,600 shares in the last quarter. Bank of Montreal Can grew its holdings in shares of Safeguard Scientifics by 1.5% in the first quarter. Bank of Montreal Can now owns 514,945 shares of the asset manager’s stock valued at $5,587,000 after purchasing an additional 7,474 shares in the last quarter. Almitas Capital LLC grew its holdings in shares of Safeguard Scientifics by 63.5% in the first quarter. Almitas Capital LLC now owns 402,998 shares of the asset manager’s stock valued at $4,373,000 after purchasing an additional 156,580 shares in the last quarter. Zeke Capital Advisors LLC purchased a new position in shares of Safeguard Scientifics in the first quarter valued at $2,212,000. Finally, Geode Capital Management LLC grew its holdings in shares of Safeguard Scientifics by 5.1% in the fourth quarter. Geode Capital Management LLC now owns 191,298 shares of the asset manager’s stock valued at $1,648,000 after purchasing an additional 9,318 shares in the last quarter. Hedge funds and other institutional investors own 68.28% of the company’s stock.

Shares of Safeguard Scientifics stock traded down $0.27 on Monday, hitting $11.39. 59,643 shares of the company traded hands, compared to its average volume of 66,400. The firm has a market cap of $239.92 million, a PE ratio of -14.99 and a beta of 0.88. The company has a quick ratio of 1.06, a current ratio of 1.06 and a debt-to-equity ratio of 0.03. Safeguard Scientifics has a 52 week low of $7.98 and a 52 week high of $12.91. The company’s 50-day moving average price is $12.11.

About Safeguard Scientifics

Safeguard Scientifics, Inc no longer investing. It is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage, and early stage financings. It initially invests in a Series A-C round and opportunistically in a seed round.

Featured Story: The Structure of a Futures Contract

Get a free copy of the Zacks research report on Safeguard Scientifics (SFE)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Safeguard Scientifics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Safeguard Scientifics and related companies with MarketBeat.com's FREE daily email newsletter.